ATE399207T1 - Lipoxygenaseproteine und für diese kodierende polynukleotide - Google Patents

Lipoxygenaseproteine und für diese kodierende polynukleotide

Info

Publication number
ATE399207T1
ATE399207T1 AT00923241T AT00923241T ATE399207T1 AT E399207 T1 ATE399207 T1 AT E399207T1 AT 00923241 T AT00923241 T AT 00923241T AT 00923241 T AT00923241 T AT 00923241T AT E399207 T1 ATE399207 T1 AT E399207T1
Authority
AT
Austria
Prior art keywords
lipoxygenase
polynucleotides encoding
proteins
lipoxygenase proteins
novel
Prior art date
Application number
AT00923241T
Other languages
English (en)
Inventor
C Turner
Brian Zambrowicz
Michael Nehls
Glenn Friedrich
Arthur Sands
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE399207T1 publication Critical patent/ATE399207T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00923241T 1999-04-12 2000-04-12 Lipoxygenaseproteine und für diese kodierende polynukleotide ATE399207T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12881799P 1999-04-12 1999-04-12
US15045499P 1999-08-24 1999-08-24

Publications (1)

Publication Number Publication Date
ATE399207T1 true ATE399207T1 (de) 2008-07-15

Family

ID=26826972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00923241T ATE399207T1 (de) 1999-04-12 2000-04-12 Lipoxygenaseproteine und für diese kodierende polynukleotide

Country Status (9)

Country Link
US (4) US6582957B1 (de)
EP (1) EP1171609B1 (de)
JP (1) JP2002541810A (de)
AT (1) ATE399207T1 (de)
AU (1) AU777409B2 (de)
CA (1) CA2365916A1 (de)
DE (1) DE60039290D1 (de)
DK (1) DK1171609T3 (de)
WO (1) WO2000061765A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137101A1 (en) * 2000-05-19 2002-09-26 Meyers Rachel A. 46638, a novel human lipoxygenase family member and uses thereof
CA2465261A1 (en) * 2001-10-24 2003-05-01 The Regents Of The University Of California Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
US20030080191A1 (en) * 2001-10-26 2003-05-01 Allen Lubow Method and apparatus for applying bar code information to products during production
US20050131733A1 (en) * 2001-12-17 2005-06-16 Allen Lubow Sealable individual bar coded packets
WO2003052681A1 (en) * 2001-12-17 2003-06-26 International Barcode Corporation Double-sided bar code doubling as a single bar code
WO2005018556A2 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
RU2006105101A (ru) 2003-08-27 2007-10-10 3М Инновейтив Пропертиз Компани (US) Арилокси и арилалкиленокси замещенные имидазохинолины
WO2005023190A2 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
US8598192B2 (en) 2003-11-14 2013-12-03 3M Innovative Properties Company Hydroxylamine substituted imidazoquinolines
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AR046781A1 (es) 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
WO2005066170A1 (en) 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US20050267145A1 (en) * 2004-05-28 2005-12-01 Merrill Bryon A Treatment for lung cancer
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
EP1831226B1 (de) 2004-12-30 2012-08-08 3M Innovative Properties Company Chirale tetracyklische verbindungen, die interferon biosyntheze induzieren
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
CA2597587A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2006107853A2 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
EP2154153A1 (de) * 2008-08-08 2010-02-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Mutantes Alpha-Synuklein und Verwendungsverfahren dafür
WO2011153121A2 (en) * 2010-06-01 2011-12-08 Board Of Supervisors Of Louisiana State University. And Agricultural And Mechanical College A soluble and stable human 5-lipoxygenase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02453A (ja) * 1987-12-28 1990-01-05 Japan Tobacco Inc ヒト５−リポキシゲナーゼポリペプチドをコードする遺伝子
CA2077461C (en) * 1992-08-28 2000-02-15 Jerry L. Nadler Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway
CA2303404A1 (en) * 1997-09-11 1999-03-18 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
US6204037B1 (en) * 1998-04-16 2001-03-20 Vanderbilt University Lipoxygenase proteins and nucleic acids

Also Published As

Publication number Publication date
WO2000061765A3 (en) 2001-02-22
DE60039290D1 (de) 2008-08-07
US7144730B2 (en) 2006-12-05
DK1171609T3 (da) 2008-08-11
AU4340000A (en) 2000-11-14
AU777409B2 (en) 2004-10-14
CA2365916A1 (en) 2000-10-19
US6582957B1 (en) 2003-06-24
WO2000061765A2 (en) 2000-10-19
EP1171609B1 (de) 2008-06-25
EP1171609A2 (de) 2002-01-16
US20080125578A1 (en) 2008-05-29
US20030172391A1 (en) 2003-09-11
JP2002541810A (ja) 2002-12-10
US20070136832A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
DE60039290D1 (de) Lipoxygenaseproteine und für diese kodierende polynukleotide
Miyata et al. Primary structure of hemorrhagic protein, HR2a, isolated from the venom of Trimeresurus flavoviridis
ATE430197T1 (de) Fibroblasten wachstumsfaktor-ähnliche polypeptide
TR200103297T2 (tr) Nöral ve renal gelişmenin uyarılması için Ret ligandı (RetL)
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
ATE371727T1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
ATE323510T1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
ATE309536T1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
EP0711173A4 (de) Isolierte peptide, die mit mhc mulekül hla-c-klon 10 komplexe bilden und ihre verwendungen
EP1187591A4 (de) Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung
ATE335086T1 (de) Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten
WO2001046260A3 (en) Novel immunoglobulin superfamily members apex-1, apex-2 and apex-3 and uses thereof
EA200400812A1 (ru) Секретируемый белок
DE69728897D1 (de) Saeugetierchemokine
BR9710919A (pt) Proteina purificada sr-p70
ATE338126T1 (de) Dna-sequenz und rekombinante herstellung eines graminaen-allergens
EA200300642A1 (ru) Связанные с шизофренией ген и белок потенциал-зависимого воротного ионного канала
HUP9802289A2 (hu) Limfocita specifikus interferon szabályozó faktor (LSIRF) polipeptideket kódoló gének
DE60039708D1 (de) Menschliches chordin und polynukleotiden die dafür kodieren
CA2530731A1 (en) Peptide having apoptosis-inhibiting activity
ATE366261T1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
ATE438660T1 (de) Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
WO2001094417A3 (en) Novel human seven transmembrane proteins and polynucleotides encoding the same
KR20000023669A (ko) 잠재형 ＴＧＦ-β의 활성화를 촉진하는 펩티드 및 ＴＧＦ-β 활성조절 화합물의 스크리닝 방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties